Amkay Products Reports Widened Loss in Half-Year Results
Amkay Products Limited, a medical device manufacturer, reported financial results for H1 2025 ending September 30. Despite a 7.8% increase in revenue to Rs 2,340.45 lakhs, the company's net loss widened by 30.1% to Rs 196.80 lakhs compared to H1 2024. Total expenses rose to Rs 2,071.65 lakhs. The Board approved these unaudited results on November 12, 2025, with statutory auditors issuing an unmodified opinion. The company will reopen its trading window 48 hours after the public announcement of results, in compliance with SEBI regulations.
*this image is generated using AI for illustrative purposes only.
Amkay Products Limited, a manufacturer of medical devices and disposables, has disclosed its financial results for the half-year ended September 30, 2025, revealing a widened net loss and increased expenses despite a rise in revenue.
Financial Performance
The company reported a net loss of Rs 196.80 lakhs for the half-year, compared to a loss of Rs 151.31 lakhs in the corresponding period of the previous year. This represents an increase in losses of approximately 30.1% year-over-year.
| Financial Metric | H1 2025 (Rs Lakhs) | H1 2024 (Rs Lakhs) | Change (%) |
|---|---|---|---|
| Total Revenue | 2,340.45 | 2,171.45 | +7.8% |
| Total Expenses | 2,071.65 | Not Provided | N/A |
| Net Loss | 196.80 | 151.31 | +30.1% |
Despite the increased loss, Amkay Products saw a 7.8% year-over-year growth in total revenue, which rose to Rs 2,340.45 lakhs from Rs 2,171.45 lakhs in the previous year. However, this revenue growth was offset by a rise in total expenses, which reached Rs 2,071.65 lakhs for the period.
Board Meeting and Audit Review
The Board of Directors of Amkay Products Limited convened on November 12, 2025, to approve the unaudited financial results. The meeting, which was held through video conferencing, commenced at 4:30 p.m. and concluded at 5:25 p.m.
The company's statutory auditors, M/s. R K Jagetiya & Co., Chartered Accountants (Firm Registration No. 146264W), have issued an unmodified opinion in their Limited Review Report on the unaudited financial results. This indicates that the auditors did not find any material misstatements or issues that would require modifications to the financial statements.
Regulatory Compliance and Trading Window
In compliance with SEBI regulations, Amkay Products has declared that the trading window for dealing in the company's securities will reopen 48 hours after the public announcement of the results. This measure is in line with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, aimed at preventing insider trading and ensuring fair market practices.
Investors and stakeholders should note that while the company has experienced revenue growth, the widening losses and increased expenses may require closer scrutiny of Amkay Products' operational efficiency and cost management strategies in the coming quarters.
